Transcat Analyst Price Targets

Transcat Inc

TRNSNASDAQ

$84.88

-1.61-1.86%

al cierre: Aug 31, 5:00 PM EST

$84.88

-1.61-1.86%

Premercado: 3:00 AM EST

Fusiones y adquisiciones: Southeastern Biomedical Associates Incorporated was acquired by Transcat (TRNS) on Monday, August 31, 2026 for $12.8M

Wall Street analyst price targets and consensus rating for Transcat (TRNS).

Price Target Range — 8 Quarters

Analyst Consensus — 4 Analysts

3Buy

1Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$108Upside to Avg. PT+26.9%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 26, 2025	HC Wainwright & Co.	Scott Buck	Maintained	Buy	$116
Aug 22, 2025	HC Wainwright & Co.	Scott Buck	Maintained	Buy	$116
Jul 10, 2025	Lake Street	—	Initiate	Buy	$105
Jun 25, 2025	HC Wainwright & Co.	Scott Buck	Maintained	Buy	$116
May 21, 2025	HC Wainwright & Co.	Scott Buck	PT Raise	Buy	$106→$116
Jan 29, 2025	Oppenheimer	Martin Yang	Downgrade	Outperform→Perform	—
Jan 29, 2025	Northland Capital Markets	Ted Jackson	PT Cut	Market Perform	$110→$85
Jan 29, 2025	HC Wainwright & Co.	Scott Buck	PT Cut	Buy	$126→$106
Dec 12, 2024	Craig-Hallum	Greg Palm	PT Raise	Buy	$113→$125
Oct 30, 2024	Northland Capital Markets	Ted Jackson	PT Cut	Market Perform	$130→$110
Oct 30, 2024	Oppenheimer	Martin Yang	PT Cut	Outperform	$155→$130
Oct 30, 2024	HC Wainwright & Co.	Scott Buck	PT Cut	Buy	$156→$126
Oct 30, 2024	Craig-Hallum	Greg Palm	PT Cut	Buy	$138→$113
Oct 29, 2024	HC Wainwright & Co.	Scott Buck	Maintained	Buy	$156
Jul 31, 2024	Craig-Hallum	Greg Palm	PT Cut	Buy	$150→$138
Jul 31, 2024	HC Wainwright & Co.	Scott Buck	Maintained	Buy	$156
Jul 30, 2024	HC Wainwright & Co.	Scott Buck	Maintained	Buy	$156
May 22, 2024	Oppenheimer	Martin Yang	PT Raise	Outperform	$125→$160
May 22, 2024	HC Wainwright & Co.	Scott Buck	PT Raise	Buy	$124→$156
Apr 18, 2024	Oppenheimer	Martin Yang	PT Raise	Outperform	$120→$125